21 - 23 out of 23Page size: 10
Sort by: Title

  1. Isopimaric Acid Derivatives as Potential Dual PPARα/γ Agonists in the Treatment of Metabolic Syndrome

    Blokhin, M. E., Borisov, S. A., Gromova, M. A., Meshkova, Y. V., Zhukova, N. A., Nikonova, S. V., Zhurakovsky, I. P., Luzina, O. A., Khvostov, M. V., Kudlay, D. A. & Salakhutdinov, N. F., 5 Sept 2025, In: Scientia Pharmaceutica. 93, 3, 44.

    Research output: Contribution to journal › Article › peer-review

  2. Design and Biological Evaluation of Monoterpene-Conjugated (S)-2-Ethoxy-3-(4-(4-hydroxyphenethoxy)phenyl)propanoic Acids as New Dual PPARα/γ Agonists

    Borisov, S. A., Blokhin, M. E., Meshkova, Y. V., Marenina, M. K., Zhukova, N. A., Pavlova, S. V., Lastovka, A. V., Fomenko, V. V., Zhurakovsky, I. P., Luzina, O. A., Khvostov, M. V., Kudlay, D. A. & Salakhutdinov, N. F., 14 Dec 2025, In: Molecules. 30, 24, 23 p., 4775.

    Research output: Contribution to journal › Article › peer-review

  3. Adjunct EF-M2 therapy improves clinical activity, steroid-sparing, and macrophage-linked biomarkers in feline chronic enteropathy: A randomized, double-blind, and placebo-controlled trial

    Pokushalov, E., Garcia, C., Smith, J., Kudlay, D., Revkov, N., Shcherbakova, A., Johnson, M. & Miller, R., Dec 2025, In: Veterinary World. 18, 12, p. 3914-3928 15 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 Next

ID: 65414320